The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage ...

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

By a 5-2 vote, the Advisory Committee on Immunization Practices endorsed Merck’s Enflonsia for babies born during or entering their first RSV season.

Possible “tripledemic” Some experts are concerned that RSV, coupled with COVID and the flu, may result in what’s being dubbed as a “tripledemic” this winter.

People with an underlying disease, RSV, should be treated similarly to other high-risk groups since an overreaction from the immune system can lead to disease progression. COVID-19 and RSV have a ...

And respiratory syncytial virus (RSV) is still putting people in the hospital, albeit at lower levels than flu or COVID. Yet despite all the sniffles, it’s shaping up to be a fairly typical year ...

Bad cases of COVID-19, flu or RSV can end up killing you. There’s also the longstanding problem of possibly getting long COVID after a severe acute respiratory syndrome coronavirus 2 infection.

Influenza, RSV, COVID-19 and norovirus have all seen heightened activity in Louisville and around the U.S. this winter, health officials say, as a so-called "quademic" looms.